Experience of Application of the ELISA Method for Detection of Antibodies to Ebola Virus during the SAET Team Work in the Republic of Guinea

The aim of the work was to develop a kit for detection of IgM and IgG antibodies to Ebola virus in ELISA.

Materials and methods. Ebola virus strain Zaire H.sapiens-wt/GIN/2015/Kalidie-Kindia-1022 grown on cell culture was used as antigen.

Results and conclusions. The kit was used by the Rospotrebnadzor SAET team in its work in Guinea while investigating cases during Ebola fever epidemics. It was established that specific IgG antibodies persisted in Ebola fever survivors for 2 years. Application of this kit in the laboratory diagnostics permits ELISA to become the main and confirmatory laboratory method of Ebola fever detection.

1. Lopatin A.A., Naydenova E.V., Safronov V.A., Razdorskiy A.S., Utkin D.V., Kas’yan Zh.A., Kritskiy A.A., Ternovoy V.A., Nesterov A.E., Sergeev A.A., Sylla A.L., Kanomou V., Boiro M.Y., Demina Yu.V., Khoroshilov V.Yu., Popova A.Yu., Kutyrev V.V. Studies on Ebola virus persistence in the body fluids of a patient at advanced stages of convalescence. Probl. Osobo Opasnykh Inf. 2015; 3:73–7.

2. Popova A.Yu., Safronov V.A., Magasuba N.F., Utkin D.V., Odinokov G.N., P’yankov O.V., Sergeev A.A., Bodnev S.A., Kabanov A.S., Kuklev V.E., Lopatin A.A., Razdorskiy A.S., Nikiforov K.A., Shcherbakova S.A., Ternovoy V.A., Agafonov A.P., Mikheev V.N., Kutyrev V.V. Management and performance of diagnostic investigations on the platform of specialized anti-epidemic team mobile complex during EVD epidemics in 2014 in the Republic of Guinea. Probl. Osobo Opasnykh Inf. 2014; 4:5–8.

3. Popova A.Yu., Kutyrev V.V., eds. Epidemiology, prophylaxis and laboratory diagnostics of Ebola virus disease. Saratov: Bukva; 2015. 244 p.

4. Baize S., Pannetier D., Oestereich L., Rieger T., Koivogui L., Magassouba N’Faly, Soropogu B., Mamadou Saliou Sow, Keïta S., De Clerck H., Tiffany A., Dominguez G., Loua M., Traoré A., Kolié M., Malano E.R., Heleze E., Bocquin A., Mély S., Raoul H., Caro V., Cadar D., Gabriel M., Pahlmann M., Tappe D., Schmidt-Chanasit J., Impouma B., Diallo A.K., Formenty P., Van Herp M., Günther S. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014; 371(15):1418–25. DOI: 10.1056/NEJMoa1404505.

5. Centers for Disease Control and Prevention (CDC). Outbreaks Chronology: Ebola Virus disease. 2014. [cited 06 Sept 2014]. Available from: http://www.cdc.gov/vhf/ebola/resources/outbreak-table.html.

6. Krähling V., Becker D., Rohde C., Eickmann M., Eroğlu Y., Herwig A., Kerber R., Kowalski K., Vergara-Alert J., Becker S. European Mobile Laboratory consortium. Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus. Med. Microbiol. Immunol. 2016; 205(2):173–83. DOI: 10.1007/s00430-015-0438-6.

7. Vu H., Shulenin S., Grolla A., Audet J., He S., Kobinger G., Unfer R.C., Warfield K.L., Aman M.J., Holtsberg F.W. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans. Antiviral. Res. 2016; 126:55– 61. DOI: 10.1016/j.antiviral.2015.11.012.

8. WHO. Situation report, 28 April 2016. [cited 14 Jul 2016]. Available from: http://apps.who.int/iris/bitstream/10665/205686/1/WHOsitrep_28Apr2016_eng.pdf?ua=1.